{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:54:31Z","timestamp":1790128471188,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jcyt.2018.10.006","type":"journal-article","created":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T09:17:07Z","timestamp":1541409427000},"page":"96-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"title":["Exosome-transmitted LINC00461 promotes multiple myeloma cell proliferation and suppresses apoptosis by modulating microRNA\/BCL-2 expression"],"prefix":"10.1016","volume":"21","author":[{"given":"Mingyang","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2018.10.006_bib0001","doi-asserted-by":"crossref","DOI":"10.1080\/10428194.2018.1448084","article-title":"Navigating the changing multiple myeloma treatment landscape: clinical practice patterns of MM patients treated in- and outside German DSMM study group trials","author":"Gengenbach","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0002","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/2374373517715011","article-title":"Living With Multiple Myeloma: A Focus Group Study of Unmet Needs and Preferences for Survivorship Care","volume":"5","author":"Monterosso","year":"2018","journal-title":"J Patient Exp"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0003","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13045-018-0589-1","article-title":"Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1\/PD-L1 pathway","volume":"11","author":"Tremblay-LeMay","year":"2018","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0004","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12254-018-0383-3","article-title":"Short overview on the current standard of treatment in newly diagnosed multiple myeloma","volume":"11","author":"Willenbacher","year":"2018","journal-title":"Memo"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0005","doi-asserted-by":"crossref","DOI":"10.1080\/10428194.2018.1452221","article-title":"Multiple myeloma - a cure within reach","author":"Gertz","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0006","doi-asserted-by":"crossref","DOI":"10.1111\/ejh.13071","article-title":"The start of a new wave: developments in proteasome inhibition in multiple myeloma","author":"Yong","year":"2018","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0007","doi-asserted-by":"crossref","unstructured":"Yuen HLA, Low MSY, Fedele P, Kalff A, Walker P, Bergin K, et al. DCEP as a bridge to ongoing therapies for advanced relapsed and\/or refractory multiple myeloma. Leuk Lymphoma 2018. https:\/\/doi.org\/10.1080\/10428194.2018.1454595","DOI":"10.1080\/10428194.2018.1454595"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0008","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.molmed.2018.01.001","article-title":"Therapeutic Targeting of Long Non-Coding RNAs in Cancer","volume":"24","author":"Arun","year":"2018","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0009","doi-asserted-by":"crossref","first-page":"e22008","DOI":"10.1002\/jbt.22008","article-title":"LncRNA NEAT1 promotes dexamethasone resistance in multiple myeloma by targeting miR-193a\/MCL1 pathway","volume":"32","author":"Wu","year":"2018","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbrc.2018.02.211","article-title":"LncRNA PDIA3P interacts with c-Myc to regulate cell proliferation via induction of pentose phosphate pathway in multiple myeloma","volume":"498","author":"Yang","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0011","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1038\/s41375-018-0067-3","article-title":"Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity","volume":"32","author":"Amodio","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0012","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/ejh.12908","article-title":"Deregulated expression of long non-coding RNA UCA1 in multiple myeloma","volume":"99","author":"Sedlarikova","year":"2017","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0013","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1186\/1471-2407-14-809","article-title":"MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression","volume":"14","author":"Cho","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0014","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s13277-014-2850-8","article-title":"Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer","volume":"36","author":"Pang","year":"2015","journal-title":"Tumour Biol"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0015","doi-asserted-by":"crossref","first-page":"7976","DOI":"10.1038\/s41598-017-08348-5","article-title":"STAT3-induced long noncoding RNAs in multiple myeloma cells display different properties in cancer","volume":"7","author":"Binder","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0016","doi-asserted-by":"crossref","first-page":"9387","DOI":"10.1021\/acs.langmuir.7b04080","article-title":"Dynamic Scaling of Exosome Sizes","volume":"34","author":"Paulaitis","year":"2018","journal-title":"Langmuir"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0017","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fcell.2018.00018","article-title":"Exosome-Based Cell-Cell Communication in the Tumor Microenvironment","volume":"6","author":"Maia","year":"2018","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0018","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/path.4712","article-title":"Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression","volume":"239","author":"Wang","year":"2016","journal-title":"J Pathol"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0019","doi-asserted-by":"crossref","first-page":"9701","DOI":"10.1074\/jbc.M114.620872","article-title":"p15RS\/RPRD1A (p15INK4b-related sequence\/regulation of nuclear pre-mRNA domain-containing protein 1A) interacts with HDAC2 in inhibition of the Wnt\/beta-catenin signaling pathway","volume":"290","author":"Liu","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0020","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/cmi.2016.49","article-title":"p38alpha has an important role in antigen cross-presentation by dendritic cells","volume":"15","author":"Zhou","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0021","doi-asserted-by":"crossref","first-page":"789","DOI":"10.7150\/thno.18133","article-title":"Progress in Exosome Isolation Techniques","volume":"7","author":"Li","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0022","doi-asserted-by":"crossref","first-page":"27031","DOI":"10.3402\/jev.v4.27031","article-title":"Optimized exosome isolation protocol for cell culture supernatant and human plasma","volume":"4","author":"Lobb","year":"2015","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0023","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/cdd.2014.87","article-title":"Role of miR-15\/16 in CLL","volume":"22","author":"Pekarsky","year":"2015","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0024","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1042\/BST20180079","article-title":"MSC exosome works through a protein-based mechanism of action","volume":"46","author":"Toh","year":"2018","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0025","doi-asserted-by":"crossref","first-page":"14814","DOI":"10.18632\/oncotarget.7442","article-title":"Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma","volume":"7","author":"Ronchetti","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0026","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cca.2017.12.009","article-title":"mRNA, microRNA and lncRNA as novel bladder tumor markers","volume":"477","author":"Wieczorek","year":"2018","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0027","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.18632\/oncotarget.23585","article-title":"Upregulation of LncRNA BCYRN1 promotes tumor progression and enhances EpCAM expression in gastric carcinoma","volume":"9","author":"Ren","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0028","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.celrep.2018.03.064","article-title":"Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context","volume":"23","author":"Chiu","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0029","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopha.2018.01.162","article-title":"LncRNA-LET inhibits cell viability, migration and EMT while induces apoptosis by up-regulation of TIMP2 in human granulosa-like tumor cell line KGN","volume":"100","author":"Han","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0030","doi-asserted-by":"crossref","first-page":"e1154","DOI":"10.3390\/ijms18061154","article-title":"Non-Coding RNAs in Hodgkin Lymphoma","volume":"18","author":"Cordeiro","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0031","doi-asserted-by":"crossref","first-page":"84123","DOI":"10.18632\/oncotarget.20340","article-title":"LINC00461, a long non-coding RNA, is important for the proliferation and migration of glioma cells","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0032","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3892\/ol.2016.5400","article-title":"Transcription factor Oct4 promotes osteosarcoma by regulating lncRNA AK055347","volume":"13","author":"Fan","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0033","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1158\/1541-7786.MCR-17-0606","article-title":"Runx2 Suppression by miR-342 and miR-363 Inhibits Multiple Myeloma Progression","volume":"16","author":"Gowda","year":"2018","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0034","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/carcin\/bgs333","article-title":"miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF","volume":"34","author":"Sun","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0035","doi-asserted-by":"crossref","first-page":"60723","DOI":"10.18632\/oncotarget.11032","article-title":"Role of micro-RNAs in drug resistance of multiple myeloma","volume":"7","author":"Abdi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0036","doi-asserted-by":"crossref","first-page":"30876","DOI":"10.18632\/oncotarget.9021","article-title":"Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jcyt.2018.10.006_bib0037","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.0506654102","article-title":"miR-15 and miR-16 induce apoptosis by targeting BCL2","volume":"102","author":"Cimmino","year":"2005","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146532491830642X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146532491830642X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:37:38Z","timestamp":1761442658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S146532491830642X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S146532491830642X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2018.10.006","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exosome-transmitted LINC00461 promotes multiple myeloma cell proliferation and suppresses apoptosis by modulating microRNA\/BCL-2 expression","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2018.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}